Index
1 Market Overview
1.1 Product Overview and Scope of Third-Party Clinical Laboratory
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Third-Party Clinical Laboratory by Type
1.3.1 Overview: Global Third-Party Clinical Laboratory Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Third-Party Clinical Laboratory Consumption Value Market Share by Type in 2022
1.3.3 Large-Scale General Inspection Laboratory
1.3.4 Specialized Special Inspection Laboratory
1.4 Global Third-Party Clinical Laboratory Market by Application
1.4.1 Overview: Global Third-Party Clinical Laboratory Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Health Care Institution
1.4.4 Others
1.5 Global Third-Party Clinical Laboratory Market Size & Forecast
1.6 Global Third-Party Clinical Laboratory Market Size and Forecast by Region
1.6.1 Global Third-Party Clinical Laboratory Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Third-Party Clinical Laboratory Market Size by Region, (2018-2029)
1.6.3 North America Third-Party Clinical Laboratory Market Size and Prospect (2018-2029)
1.6.4 Europe Third-Party Clinical Laboratory Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Third-Party Clinical Laboratory Market Size and Prospect (2018-2029)
1.6.6 South America Third-Party Clinical Laboratory Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Third-Party Clinical Laboratory Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 QUEST
2.1.1 QUEST Details
2.1.2 QUEST Major Business
2.1.3 QUEST Third-Party Clinical Laboratory Product and Solutions
2.1.4 QUEST Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 QUEST Recent Developments and Future Plans
2.2 LABCORP
2.2.1 LABCORP Details
2.2.2 LABCORP Major Business
2.2.3 LABCORP Third-Party Clinical Laboratory Product and Solutions
2.2.4 LABCORP Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 LABCORP Recent Developments and Future Plans
2.3 Adicon
2.3.1 Adicon Details
2.3.2 Adicon Major Business
2.3.3 Adicon Third-Party Clinical Laboratory Product and Solutions
2.3.4 Adicon Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Adicon Recent Developments and Future Plans
2.4 Kindstar Globalgene
2.4.1 Kindstar Globalgene Details
2.4.2 Kindstar Globalgene Major Business
2.4.3 Kindstar Globalgene Third-Party Clinical Laboratory Product and Solutions
2.4.4 Kindstar Globalgene Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kindstar Globalgene Recent Developments and Future Plans
2.5 Siemens AG
2.5.1 Siemens AG Details
2.5.2 Siemens AG Major Business
2.5.3 Siemens AG Third-Party Clinical Laboratory Product and Solutions
2.5.4 Siemens AG Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Siemens AG Recent Developments and Future Plans
2.6 Sonic Healthcare Limited
2.6.1 Sonic Healthcare Limited Details
2.6.2 Sonic Healthcare Limited Major Business
2.6.3 Sonic Healthcare Limited Third-Party Clinical Laboratory Product and Solutions
2.6.4 Sonic Healthcare Limited Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sonic Healthcare Limited Recent Developments and Future Plans
2.7 Dian Diagnostics Group
2.7.1 Dian Diagnostics Group Details
2.7.2 Dian Diagnostics Group Major Business
2.7.3 Dian Diagnostics Group Third-Party Clinical Laboratory Product and Solutions
2.7.4 Dian Diagnostics Group Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dian Diagnostics Group Recent Developments and Future Plans
2.8 Medicalsystem Biotechnology
2.8.1 Medicalsystem Biotechnology Details
2.8.2 Medicalsystem Biotechnology Major Business
2.8.3 Medicalsystem Biotechnology Third-Party Clinical Laboratory Product and Solutions
2.8.4 Medicalsystem Biotechnology Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Medicalsystem Biotechnology Recent Developments and Future Plans
2.9 BGI Genomics
2.9.1 BGI Genomics Details
2.9.2 BGI Genomics Major Business
2.9.3 BGI Genomics Third-Party Clinical Laboratory Product and Solutions
2.9.4 BGI Genomics Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BGI Genomics Recent Developments and Future Plans
2.10 Hybribio Biotech
2.10.1 Hybribio Biotech Details
2.10.2 Hybribio Biotech Major Business
2.10.3 Hybribio Biotech Third-Party Clinical Laboratory Product and Solutions
2.10.4 Hybribio Biotech Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hybribio Biotech Recent Developments and Future Plans
2.11 Daan Gene
2.11.1 Daan Gene Details
2.11.2 Daan Gene Major Business
2.11.3 Daan Gene Third-Party Clinical Laboratory Product and Solutions
2.11.4 Daan Gene Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Daan Gene Recent Developments and Future Plans
2.12 Kingmed Diagnostics Group
2.12.1 Kingmed Diagnostics Group Details
2.12.2 Kingmed Diagnostics Group Major Business
2.12.3 Kingmed Diagnostics Group Third-Party Clinical Laboratory Product and Solutions
2.12.4 Kingmed Diagnostics Group Third-Party Clinical Laboratory Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Kingmed Diagnostics Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Third-Party Clinical Laboratory Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Third-Party Clinical Laboratory by Company Revenue
3.2.2 Top 3 Third-Party Clinical Laboratory Players Market Share in 2022
3.2.3 Top 6 Third-Party Clinical Laboratory Players Market Share in 2022
3.3 Third-Party Clinical Laboratory Market: Overall Company Footprint Analysis
3.3.1 Third-Party Clinical Laboratory Market: Region Footprint
3.3.2 Third-Party Clinical Laboratory Market: Company Product Type Footprint
3.3.3 Third-Party Clinical Laboratory Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Third-Party Clinical Laboratory Consumption Value and Market Share by Type (2018-2023)
4.2 Global Third-Party Clinical Laboratory Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Third-Party Clinical Laboratory Consumption Value Market Share by Application (2018-2023)
5.2 Global Third-Party Clinical Laboratory Market Forecast by Application (2024-2029)
6 North America
6.1 North America Third-Party Clinical Laboratory Consumption Value by Type (2018-2029)
6.2 North America Third-Party Clinical Laboratory Consumption Value by Application (2018-2029)
6.3 North America Third-Party Clinical Laboratory Market Size by Country
6.3.1 North America Third-Party Clinical Laboratory Consumption Value by Country (2018-2029)
6.3.2 United States Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
6.3.3 Canada Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
6.3.4 Mexico Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Third-Party Clinical Laboratory Consumption Value by Type (2018-2029)
7.2 Europe Third-Party Clinical Laboratory Consumption Value by Application (2018-2029)
7.3 Europe Third-Party Clinical Laboratory Market Size by Country
7.3.1 Europe Third-Party Clinical Laboratory Consumption Value by Country (2018-2029)
7.3.2 Germany Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
7.3.3 France Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
7.3.5 Russia Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
7.3.6 Italy Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Third-Party Clinical Laboratory Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Third-Party Clinical Laboratory Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Third-Party Clinical Laboratory Market Size by Region
8.3.1 Asia-Pacific Third-Party Clinical Laboratory Consumption Value by Region (2018-2029)
8.3.2 China Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
8.3.3 Japan Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
8.3.4 South Korea Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
8.3.5 India Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
8.3.7 Australia Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
9 South America
9.1 South America Third-Party Clinical Laboratory Consumption Value by Type (2018-2029)
9.2 South America Third-Party Clinical Laboratory Consumption Value by Application (2018-2029)
9.3 South America Third-Party Clinical Laboratory Market Size by Country
9.3.1 South America Third-Party Clinical Laboratory Consumption Value by Country (2018-2029)
9.3.2 Brazil Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
9.3.3 Argentina Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Third-Party Clinical Laboratory Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Third-Party Clinical Laboratory Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Third-Party Clinical Laboratory Market Size by Country
10.3.1 Middle East & Africa Third-Party Clinical Laboratory Consumption Value by Country (2018-2029)
10.3.2 Turkey Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
10.3.4 UAE Third-Party Clinical Laboratory Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Third-Party Clinical Laboratory Market Drivers
11.2 Third-Party Clinical Laboratory Market Restraints
11.3 Third-Party Clinical Laboratory Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Third-Party Clinical Laboratory Industry Chain
12.2 Third-Party Clinical Laboratory Upstream Analysis
12.3 Third-Party Clinical Laboratory Midstream Analysis
12.4 Third-Party Clinical Laboratory Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer